Autopsy report · NCT04165551

Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.

“The study was terminated due to low enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 11 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Biosearch S.A.

Sponsor type

Industry

Conditions

Streptococcus Agalactiae

Interventions

Probiotic; Placebo

Participants

3

Sites

1

Countries

Spain

Trials that died the same way

• BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
  “Study was terminated due to low enrollment.” (98% match in meaning)
• Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
  “the study was terminated early due to poor enrollment” (97% match in meaning)
• Use of Teriparatide to Accelerate Fracture Healing
  “The study was terminated due to poor enrollment.” (97% match in meaning)
• Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
  “The study is terminated due to lower enrollment” (96% match in meaning)
• Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
  “This study was terminated due to low participant enrollment.” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.